ICCM
IceCure Medical Ltd [ICCM] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
ICCM Stock Summary
In the News
ICCM Financial details
Company Rating
-
Market Cap
57.16M
Income
-14.62M
Revenue
3.3M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
71
Optionable
No
Shortable
Yes
Earnings
27 May 2024
P/E
-3.9
Forward P/E
-
PEG
1.22
P/S
19.23
P/B
4.07
P/C
-
P/FCF
-3.86
Quick Ratio
1.14
Current Ratio
4.03
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.32
EPS next Y
-
EPS next Q
-
EPS this Y
-31.91%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-1.78%
Revenue last 5Y
14.27%
Revenue Q/Q
304%
EPS Q/Q
-21.32%
-
-
-
-
SMA20
-1.94%
SMA50
-15.13%
SMA100
-17.89%
Inst Own
-
Inst Trans
-
ROA
-80%
ROE
-77%
ROC
-1.06%
Gross Margin
41%
Oper. Margin
-552%
Profit Margin
-530%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.52-1.57
52W High
-
52W Low
-
RSI
39.28
Rel Volume
0.41
Avg Volume
497.18K
Volume
205.86K
Perf Week
-5.63%
Perf Month
-16.21%
Perf Quarter
-16.21%
Perf Half Y
16.41%
-
-
-
-
Beta
2.97
-
-
Volatility
0.02%, 0.04%
Prev Close
-1.82%
Price
0.972
Change
-2.8%
Company Profile
- Volume Average 497.18K
- Market Capitalization 57.16M
- Employee 71
- CEO Mr. Eyal Shamir
- Headquarters Caesarea,IL
- IPO Date 2021-08-26
-
Website
https://www.icecure-medical.com 
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
